EUVIMED · CrossrefZeitschrift
Cancer Immunology Research
ISSN 2326-6066 · American Association for Cancer Research (AACR)
Neueste Artikel
IL-8 in Human Glioblastoma Tumors Instructs Immunosuppressive Myeloid Cells
Lower Airway Microbiome Transcriptional and Metabolic Activities Influence Responsiveness to Immunotherapy in NSCLC
MicroRNA core machinery maintains mitochondrial integrity to empower cancer escape from natural killer cell cytotoxicity
Disruption of the CRL5 Ubiquitin Ligase Complex Enhances Engineered T-cell Persistence under Chronic Tumor Antigen Exposure
A Library of Potent TCRs Derived from Healthy Donors Targeting Kras G12d and G12v Neoantigens
Engineered stem cell-derived CD16-enhanced universal NKT cells improve monoclonal antibody-based cancer immunotherapy
LM103, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Melanoma Resistant to Standard Therapy
FasL-Mediated Death of Activated Intratumoral T Cells Drives Secondary Resistance to Cancer Immunotherapy
Cullin-5–RING E3 Ligase Limits CD8+ T-cell Persistence and Effector Responses during Chronic Antigen Stimulation
Targeting CCR1/CCR2 Attenuates Cytokine Release Syndrome while Preserving CAR T-cell Antitumor Activity
TCR Sensitivity Shapes Recognition of Tumor Antigen Presented by Host Cells and TCR T-cell Efficacy in Solid Tumors
A Sampling of Highlights from the Literature: Article Recommendations from Our Deputy and Senior Editors
H2AFY2 Suppresses Exhaustion and Enhances Antitumor Activity of CAR T Cells through Transcriptional and Epigenetic Modifications
EphA4 Mediates Protumoral and Antitumoral Effects through Upstream Negative Regulation of AKT in Head and Neck Squamous Cell Carcinoma
CD266+ Myofibroblasts Mediate Resistance to Immunochemotherapy through ECM Stiffness in Head and Neck Squamous Cell Carcinoma
The Pretreatment Tumor Microenvironment Immune Status Determines Bacillus Calmette–Guerin Immunotherapy Response in Early-Stage Bladder Cancer
Targeting ERO1A Enhances Antitumor Immune Response by Recruiting CD8+ T Cells and Synergizing with PD-L1 Blockade in Liver Cancer
Cancer Immunotherapy Using AIRE Conditioning of the Tumor Epitopeome
TIM3 Blockade with Hypomethylating Therapy Restores NK Cell and Cytotoxic CD4+ T-cell Activity in Patients with AML or MDS
Neutralizing the IL12/IL23 p40 Subunit Prevents Immune Checkpoint Blockade Toxicity without Compromising Antitumor Efficacy
Subtype-Agnostic Biomarkers of Immunotherapy Response in Lung Cancer
Immune Checkpoint Blockade Sensitivity Is Linked to Endogenous Retroelement Transcriptional Changes in Cancer
IL21 Boosts T-cell Therapy Efficacy for Solid Tumors by Enhancing Mitochondrial Ca2+-Mediated Motility of Effector CD8+ T Cells
The Posttranscriptional Regulator HuR Promotes Immune Evasion in Pancreatic Ductal Adenocarcinoma
Addition of Chemotherapy to Radiotherapy Promotes Progenitor-Exhausted CD8+ T-cell Clonal Dominance in Head and Neck Cancer
Phenotypic and Functional Characterization of Tumor-Reactive T Cells in Malignant Pleural Effusions
ULK1-Dependent Autophagy Initiation Promotes MHC-I Degradation and Immune Evasion in HPV-Positive Head and Neck Cancer
Cullin-g the Brakes on T-cell Persistence
Macrophages Are Not Welcome: Potential of CCR1/CCR2 Inhibition for Cytokine Release Prevention
Inducible IL12- or IL18-Secreting CAR T Cells Targeting the Glyco-antigen CD176 Exhibit Potent Activity against Non–Small Cell Lung Cancer in Preclinical Models
EUVIMED